Skip to content

Clinical trials

Anxiety Disorders trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Country / region: Czechia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20191
20202
20215
20223
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Enrolling by invitation2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health, Czech Republic4
Seaport Therapeutics2
Angelini Pharma Česká republika s.r.o.1
AstraZeneca1
Charles University, Czech Republic1
Czech University of Life Sciences Prague1
Krajská zdravotní, a.s. - Nemocnice Most, o.z.1
Martin Zielina1
Sanofi1
Technische Universität Dresden1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders18
Depressive Disorder3
Major Depressive Disorder3
COVID-192
Mood Disorders2
Pain2
Adjustment Disorders1
Anhedonia1
Burns1
Coronavirus Infections1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.